• PDF / 186,059 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 104 Downloads / 150 Views

DOWNLOAD

REPORT

1173-5503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860

1

Recommend Documents

Breast Reconstruction and Postmastectomy Radiotherapy

98 52 2MB

Lenvatinib cost effective in advanced liver cancer in Australia

172 41 163KB

Olaparib cost effective for advanced BRCA -associated ovarian cancer

145 30 168KB

Cost-Effective

168 109 57MB

Atorvastatin cost effective in T2DM

163 57 182KB

Atomoxetine cost-effective in ADHD

158 88 139KB

Tucatinib not cost effective in metastatic breast cancer in China and US

104 8 163KB

Highly Cost-Effective Intervention

195 83 57MB

Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyng

134 6 1MB

Synflorix cost effective versus PCV13 in Taiwan

208 39 182KB

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis an

98 71 3MB

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

107 79 737KB